Robert A. Krance, MD
Professor, Department of Pediatrics, Division of Hematology-Oncology, Cell and Gene Therapy, Baylor College of Medicine
Correo electronico: rkrance@bcm.edu
Idiomas: English
Office location:
1102 Bates Avenue
Houston, TX 77030
Get to know Robert A. Krance, MD
Intereses Clinicos
His clinical interests include bone marrow transplantation and cell and gene therapy.
Educacion
| School | Education | Degree | Year |
|---|---|---|---|
| St. Jude Children's Research Hospital | Fellowship | Hematology-Oncology | 1977 |
| St. Jude Children's Research Hospital | Residency | Pediatrics | 1975 |
| Rocky Mountain College | Residency | Pediatrics | 1972 |
| Rush University Medical Center | Residency | Pediatrics | 1972 |
| Rocky Mountain College | Internship | Pediatrics | 1971 |
| Loyola University of Chicago | Medical School | Doctor of Medicine | 1970 |
Organizaciones
| Nombre de la Organizacion | Rol |
|---|---|
| American Academy of Pediatrics (AAP) | Member |
| American Society for Transplantation and Cellular Therapy (ASTCT) | Member |
| American Society of Clinical Oncology (ASCO) | Member |
| American Society of Hematology (ASH) | Member |
Board Certification
| Title |
|---|
| American Board of Pediatrics, American Board of Pediatrics - Hematology/Oncology |
* Texas Children’s Hospital physicians’ licenses and credentials are reviewed prior to practicing at any of our facilities. Sections titled From the Doctor, Professional Organizations and Publications were provided by the physician’s office and were not verified by Texas Children’s Hospital.
Area de investigacion:
Bone Marrow Transplant / Stem Cell Transplant
Research interests
Dr. Robert Krance's research interests include: 1) the development of transplantation using alternative donors, 2) transplantation using less than fully HLA matched related donors, and 3) the impact of viral infection post-transplantation.
Current initiatives focus on the development of transplantation using alternative donors and less than fully HLA matched related donors. Investigations are under way into the use of antibodies directed against hematopoietic cells and methods of stem cell purification. In collaboration with other investigators in the Center for Cell and Gene Therapy (CAGT), new cell-based approaches are being conducted hopefully to diminish the impact of viral infection post transplantation.